Regulatory Update on the European Serialisation Agenda – What To Expect?
In this interview Maarten Van Baelen, Medical Affairs Manager, European Generic Medicines Association (EGMA) speaks to Pharma IQ about the greatest concerns facing generic manufacturers in implementing serialisation and what’s next for European serialisation agenda.
Pharma IQ: What current trends have you witnessed in pharmaceutical traceability?
Maarten Van Baelen: First of all, the European legislation, as it dictates, it’s not a track and trace system, it’s a ser...
To continue reading this story get free access
Please note: That all fields marked with an asterisk (*) are required.